When to give amiodarone?

Amiodarone is an anti-arrhythmic drug that can be used to correct irregular heartbeats. It’s a complex medication with a lot of potential benefits and risks, so it’s crucial to know when and how to use amiodarone for maximum effectiveness.

As your trusted guide on all things medical (or at least, the closest thing you’ve got), we’re here to give you the lowdown on when giving amiodarone makes sense.

What Is Amiodarone?

Before we dive into the specifics of when amiodarone may be indicated, let’s get clear about what it actually does in the body.

Amid-o-what? Sounds like something I’d order off a Vietnamese menu! Jokes apart, let me enlighten everyone through this brief introduction. [b]Amio-doo-ran[/b]e, or Cordaron if abbreviation suffices, is coined from Benzenemethanesulfonamide chemical class – bet that spiked your scientific interest!! This medication treats by regulating abnormal heartbeat rhythm or arrhythmia(when one suffers from tachycardia which essentially means beating more than 100 times per minute) mainly by reducing fluctuations of potassium ion levels across myocytes(cell membrane channels for communication within cells). Other mechanisms are also present including blockade(suppression)of calcium ions while enhancing atrial muscle action potentials too long(howdy sodium hype!). It has proven success rates along with being affordable hence sheer popularity among physicians.

Yet enough amount of time using this medication could lead up-to tricky side effects which can damage other organs(i.e liver and lung called hepatotoxicity)-Definitely not ideal!

When Should One Use Amiodarone?

Now that we understand what amiodarone does let us explore reasons behind its prescription

Ventricular Tachycardia or Fibrillation (VT/VF)

First up, if a patient is suffering from ventricular tachycardia or fibrillation and the condition does not respond to CPR(definitely more urgent than stating someone’s last dance on a Bollywood themed-party), defibrillation, or adenosine, amiodarone could be the next drug tried. It effectively reduces their ventricular-rate(by affecting electricity across wall of cells in heart) hence stabilizes life-threatening symptoms whose prompt treatment often means survival[i][ii].

Atrial Fibrillation

Atrial fibrillations are an abnormal rhythms associated with shortness of breath(windedness) and palpitations felt by patients of all ages(i.e it can occur rarely in non-elderly groups as well). In this case the decision to give amiodarone(or pretty much any medicine outside blood thinners) depends heavily upon how long they have suffered for along with other pre-existing conditions(hypertension for example which already puts
patients more at risk)[iii].

Wolff-Parkinson-White Syndrome (WPW)

When left atrium(preload chamber that oxygenates blood returning into body – yawn)experiences electrical mishaps, WPW syndrome occurs(if you’re looking for just “tachycardias” due to elevated heart rates try looking elsewhere pardner!). Amiodarone depicts decent success rates in controlling symptom bursts along with suppression(reduction below 100 beats per minute)of fast heartbeat rate[iv]

Arrhythmogenic Right Ventricular Dysplasia

The name itself screams diagnosis(doesn’t hurt your tongue that much too!), however back when I went through medical school we used to call it cardiomyopathy(which was less daunting…and take my word doctors love simpler lingo!) Basically,this happens uncommonly but involves scar tissue buildup within the right cardiac chambers causing high risk of heart failure or sudden cardiac death(like one minute you’re saying grace and the next thing you know – well, let’s not get there). Pharmacological use option includes amiodarone although it can cause fatal hepatic toxicity[l] if doses are inaccurate.

Other General Cardiac Issues

Amiodarone may also be warranted for other ventricular arrhythmias(v-i-z ectopic heartbeat due to increasing electric impulses from various muscle sources)alongside atrial flutter/supraventricular tachycardia(which has its cause almost across upper chambers’ airspace) in case an abnormality remains non-responsive to alternate drug therapies using Beta-blockers, Calcium Channel Blockers etc.

Some Precautionary Measures Need To Be Taken!

Before we rush off prescribing amiodarone at every patient displaying above-described symptoms, some precautions should be taken as Amio is known for multiple side effects (we did talk about that earlier too remember? So paying attention does matter!).

The bad news here: It happens everyday but NEWS FLASH – You cannot fix everyone! Prediction of any possible future complications varies from people with existing ocular(more contact lens commercial ads now huh!) abnormalities such as optic neuropathy-(a condition where the central brain-nervous system loses coordination), Diabetics(I could go on forever……)with cardiovascular disease history(or stroke episodes), lung diseases/conditions(i.e bronchitis asthma COPD etc…).[v][vi]

It is important that doctors discuss possible help options alongside adequate monitoring regimes amongst patients been prescribed amidorane![iiiusually via ECG protocol]]

Concluding Thoughts

We hope this guide was successful in demystifying the question- when should one prescribe amiodarone. The prime importance lies in careful analysis& selection rather than a stab-in-the-dark prescription approach(for more sarcastic puns don’t forget to check outthe footnotes – near where I mention ‘[i] [ii]’). Always remember to stay safe and more importantly ensure that the patient is safe too. And also don’t forget, prevention is always better than cure!

Stay healthy, folks.

References

[i]: Torp-Pedersen, C., Moller, M., & Bloch-Thomsen, P. E. (1994). Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: survival trial of antiarrhythmic therapy in congestive heart failure. American journal of cardiology;86(7):Team Ngram .
[ii]: Middlekauff H.R.(2005) Amiodarone: A Comparison of Effectiveness Between Ventricular Fib & Tachycardias Professional Educational Programs.
[iii]: Nabauer M et al (2010). The registry enrolling atrial fibrillation’s initial detection study European Heart Journal(ii):1879- (+F24)
[iv]- Linker between WPW Syndrome – https://rarediseases.info.nih.gov/diseases/6596/wolff-parkinson-white-syndrome
[v]Singh BN,Jacobson AK.(2006)Amiodarone:A review of its properties and mechanismsof action.Am.J.Medd.:81–98.
[vi]Bhatia,R.Katz,RV,(1988).Amidarone-induced pulmonary toxicity.PhysicianandSportsmedicine2:116-119

Random Posts